Epigenetic inactivation of PCDH10 in human prostate cancer cell lines

Cell Biology International

Volumn 35, Issue 7, 2011, Pages 671-676

  Li, Zesong ^a,b   Li, Wenjie ^a,c   Xie, Jun ^a   Wang, Yong ^a   Tang, Aifa ^a,b   Li, Xianxin ^a   Ye, Jiongxian ^a   Gui, Yaoting ^a   Cai, Zhiming ^a,b  

^a PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

^c SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Epigenetics; PCDH10; Promoter methylation; Prostate cancer

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; PROTOCADHERIN 10; TRICHOSTATIN A; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PROMOTER REGION; PROTOCADHERIN 10 GENE; TUMOR SUPPRESSOR GENE;

ADULT; BLOTTING, WESTERN; CADHERINS; CELL LINE, TUMOR; CPG ISLANDS; CYTIDINE MONOPHOSPHATE; DNA METHYLATION; DRUG SYNERGISM; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROXAMIC ACIDS; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS;

EID: 79959214500     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20100568     Document Type: Article

References (20)

1. Cheng Y, Kim JW, Liu W, Dunn TA, Luo J, Loza MJ, et al. Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer. Prostate 2009;69:327-35.
2. Cooper CS, Foster CS. Concepts of epigenetics in prostate cancer development. Br J Cancer 2009;100:240-5.
3. Goodman JI, Watson RE. Altered DNA methylation: a secondary mechanism involved in carcinogenesis. Annu Rev Pharmacol Toxicol 2002;42:501-25.
4. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
5. Kron K, Pethe V, Briollais L, Sadikovic B, Ozcelik H, Sunderji A, et al. Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays. PLoS One 2009;4:e4830.
6. Li LC, Carroll PR, Dahiya R. Epigenetic changes in prostate cancer: implication for diagnosis and treatment. J Natl Cancer Inst 2005;97:103-15.
7. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002;18:1427-31
8. Li Z, Xie J, Li W, Tang A, Li X, Jiang Z, et al. Identification and characterization of human PCDH10 gene promoter. Gene 2011;475(1):49-56.
9. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(2Delta Delta C(T)) method. Methods 2001;25:402-8.
10. Morrow EM, Yoo SY, Flavell SW, Kim TK, Lin Y, Hill RS, et al. Identifying autism loci and genes by tracing recent shared ancestry. Science 2008;321:218-23.
11. Narayan G, Scotto L, Neelakantan V, Kottoor SH, Wong AH, Loke SL, et al. Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer. Genes Chromosomes Cancer 2009;48:983-92.
12. Richiardi L, Fiano V, Vizzini L, De Marco L, Delsedime L, Akre O, et al. Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients. J Clin ncol 2009;27:3161-8.
13. Saha B, Kaur P, Tsao-Wei D, Naritoku WY, Groshen S, Datar RH, et al. Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone. Prostate 2008;68:1681-8.
14. Schanke JT, Durning M, Johnson KJ, Bennett LK, Golos TG. SP1/SP3-binding sites and adjacent elements contribute to basal and cyclic adenosine 39,59-monophosphate-stimulated transcriptional activation of the rhesus growth hormone-variant gene in trophoblasts. Mol Endocrinol 1998;12:405-17.
15. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 009;457:910-4.
16. Uemura M, Nakao S, Suzuki ST, Takeichi M, Hirano S. OL-Protocadherin is essential for growth of striatal axons and thalamocortical projections. Nat Neurosci 2007;10:1151-.
17. Wang KH, Liu HW, Lin SR, Ding DC, Chu TY. Field methylation silencing of the protocadherin 10 gene in cervical carcinogenesis as a potential specific diagnostic test from cervical scrapings. Cancer Sci 2009;100:2175-80.
18. Wolverton T, Lalande M. Identification and characterization of three members of a novel subclass of protocadherins. Genomics 2001;76:66-72.
19. Yagi T. Clustered protocadherin family. Dev Growth Differ 2008;50 Suppl 1:S131-40.
20. Ying J, Gao Z, Li H, Srivastava G, Murray PG, Goh HK, et al. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies. Br J Haematol 2007;136: 829-32.